M Z Mazlam

528 total citations
7 papers, 435 citations indexed

About

M Z Mazlam is a scholar working on Epidemiology, Gastroenterology and Genetics. According to data from OpenAlex, M Z Mazlam has authored 7 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Epidemiology, 3 papers in Gastroenterology and 3 papers in Genetics. Recurrent topics in M Z Mazlam's work include Microscopic Colitis (3 papers), Inflammatory Bowel Disease (3 papers) and Helicobacter pylori-related gastroenterology studies (2 papers). M Z Mazlam is often cited by papers focused on Microscopic Colitis (3 papers), Inflammatory Bowel Disease (3 papers) and Helicobacter pylori-related gastroenterology studies (2 papers). M Z Mazlam collaborates with scholars based in United Kingdom, Australia and Taiwan. M Z Mazlam's co-authors include H. J. F. Hodgson, H J Hodgson, John Kellow, Satawat Thongsawat, Amy W. Wagner, J. A. Jones, Kok‐Ann Gwee, O. Y. Lee, Hok Pan Yuen and F. Y. Chang and has published in prestigious journals such as Gut, Alimentary Pharmacology & Therapeutics and The Pediatric Infectious Disease Journal.

In The Last Decade

M Z Mazlam

7 papers receiving 418 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M Z Mazlam United Kingdom	6	198	168	160	134	68	7	435
Sameer Zar United Kingdom	8	294 1.5×	195 1.2×	108 0.7×	87 0.6×	18 0.3×	16	463
J Hostein France	12	158 0.8×	228 1.4×	142 0.9×	127 0.9×	49 0.7×	49	459
Christine L. Frissora United States	9	190 1.0×	196 1.2×	34 0.2×	26 0.2×	42 0.6×	18	478
Francesca Bresso Sweden	15	171 0.9×	240 1.4×	339 2.1×	249 1.9×	73 1.1×	34	644
Valentina Passananti Italy	9	252 1.3×	124 0.7×	55 0.3×	107 0.8×	12 0.2×	14	339
Fevronia Kiparissi United Kingdom	11	172 0.9×	197 1.2×	120 0.8×	189 1.4×	32 0.5×	40	450
Brian Isgar United Kingdom	7	179 0.9×	131 0.8×	74 0.5×	108 0.8×	5 0.1×	22	372
AR Zinsmeister United States	7	148 0.7×	141 0.8×	139 0.9×	152 1.1×	10 0.1×	13	425
M Pocecco Italy	11	229 1.2×	197 1.2×	218 1.4×	153 1.1×	53 0.8×	32	480
Danilo Paduano Italy	10	126 0.6×	179 1.1×	147 0.9×	120 0.9×	14 0.2×	28	454

Countries citing papers authored by M Z Mazlam

Since Specialization

Citations

This map shows the geographic impact of M Z Mazlam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Z Mazlam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Z Mazlam more than expected).

Fields of papers citing papers by M Z Mazlam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Z Mazlam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Z Mazlam. The network helps show where M Z Mazlam may publish in the future.

Co-authorship network of co-authors of M Z Mazlam

This figure shows the co-authorship network connecting the top 25 collaborators of M Z Mazlam. A scholar is included among the top collaborators of M Z Mazlam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Z Mazlam. M Z Mazlam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Kellow, John, O. Y. Lee, F. Y. Chang, et al.. (2003). An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome. Gut. 52(5). 671–676. 191 indexed citations

2.

Mazlam, M Z, et al.. (2000). Helicobacter pylori related functional dyspepsia in a defined malaysian population.. PubMed. 7(1). 22–6. 5 indexed citations

3.

Mazlam, M Z & H J Hodgson. (1994). Why measure C reactive protein?. Gut. 35(1). 5–7. 35 indexed citations

4.

Mazlam, M Z & H J Hodgson. (1994). Interrelations between interleukin-6, interleukin-1 beta, plasma C-reactive protein values, and in vitro C-reactive protein generation in patients with inflammatory bowel disease.. Gut. 35(1). 77–83. 73 indexed citations

5.

Mazlam, M Z & H J Hodgson. (1994). WHY MEASURE C-REACTIVE PROTEIN?. The Pediatric Infectious Disease Journal. 13(12). 1162–1162. 2 indexed citations

6.

Mazlam, M Z & H. J. F. Hodgson. (1992). Peripheral blood monocyte cytokine production and acute phase response in inflammatory bowel disease.. Gut. 33(6). 773–778. 103 indexed citations

7.

Hodgson, H. J. F. & M Z Mazlam. (1991). Review article: assessment of drug therapy in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 5(6). 555–584. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact